Nascent Biotech, Inc. (NBIO)
Nascent Biotech, Inc., a clinical-stage biopharmaceutical company, develops monoclonal antibodies for the treatment of various forms of cancer. It is developing...
- Open
- --
- High
- --
- Low
- --
- Prev. Close
- 0.0003
- Volume
- 0
- Turnover
- 0
- Avg Price
- --
- Bid/Ask Ratio
- --
- Amplitude
- --
- 52wk High
- 0.1345
- Volume Ratio
- 0.00
- Turnover Ratio
- --
News
- biopharmadive · Apr 7 at 09:18 AM
BioOra and Octane Biotech Sign Letter of Intent to Expand Cell Therapy Manufacturing Using the Cocoon® Platform
- TechCrunch · Mar 30 at 09:50 AM
Mantis Biotech is making ‘digital twins’ of humans to help solve medicine’s data availability problem
- Unusual Whales · Jan 23 at 12:01 AM
Biotalys and 21st.BIO partner to advance biocontrol production; Biotalys updates funding plans for next phase of development.
